Public Policy Health Policy Pharmaceutical Law Consumer Rights Corruption Tobacco Industry Legislative Sessions Public Policy Prescription Drugs Medicare
A restructured Purdue Pharma will redirect $7.4 billion toward opioid treatment following the Sacklers' exit from U.S. opioid sales.